Market

Australia's Medicine Shortage: Causes and Solutions Explored
Management & Regulatory Australia's Medicine Shortage: Causes and Solutions Explored

Australia faces a perplexing paradox: despite its status as a developed country with significant advances in medical technology, it continues to suffer from persistent medication shortages. These shortages are largely due to the nation's heavy dependence on imported pharmaceuticals and the limited

How Does ABPDU Revolutionize U.S. Biomanufacturing?
Biotech & Bioprocessing How Does ABPDU Revolutionize U.S. Biomanufacturing?

The Advanced Biofuels and Bioproducts Process Development Unit (ABPDU) stands as a formidable force reshaping the U.S. biomanufacturing sector amid the demand for sustainable and efficient biotechnological solutions. Since its inception in 2009 under the U.S. Department of Energy's Bioenergy

Key Challenges and Innovations in Science and Pharma Sectors
Research & Development Key Challenges and Innovations in Science and Pharma Sectors

The current landscape of the scientific and pharmaceutical industries presents a fascinating blend of unprecedented advancements and complex challenges that continue to redefine the sector. As these industries evolve, they encounter critical opportunities for growth alongside significant hurdles

CROs Shift to Alternative Methods Following FDA Animal Testing Phase-Out
Research & Development CROs Shift to Alternative Methods Following FDA Animal Testing Phase-Out

Chinese contract research organization GemPharmatech has expanded its presence in the United States with a new facility in San Diego, announced on April 17. The facility is designed for laboratories and housing genetically engineered mouse models, aimed at enhancing their capabilities in offering

What Will Drive the Future of Nitinol Medical Devices?
Management & Regulatory What Will Drive the Future of Nitinol Medical Devices?

The realm of medical devices is on a transformative path, markedly influenced by the integration of advanced materials like Nitinol. Known for its remarkable superelasticity, shape memory effect, and superior damping characteristics, Nitinol stands as a cornerstone in the development of innovative

Recce Pharmaceuticals Secures $15.8M to Advance Phase 3 Trials
Research & Development Recce Pharmaceuticals Secures $15.8M to Advance Phase 3 Trials

Recce Pharmaceuticals, a Sydney-based biotechnology company, has successfully raised A$15.8 million to advance its groundbreaking anti-infective drugs into Phase 3 trials. This funding was obtained through a combination of private placement and an entitlement offer. Recce's synthetic

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later